Thursday, May 28, 2015

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the…
from Total Knee Replacement Recovery http://totalkneereplacementrecovery.tumblr.com/post/120121562574

from Tumblr http://wendyjborst.tumblr.com/post/120126437635


No comments:

Post a Comment